SEC Filing Summary: Helius Medical Technologies, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Helius Medical Technologies, Inc. (not Solana Co) on June 3, 2025. The report addresses a specific regulatory event regarding the company's listing status on The Nasdaq Stock Market LLC under the trading symbol HSDT.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the company's regained compliance with Nasdaq Listing Rule 5550(a)(2). This rule requires issuers on The Nasdaq Capital Market to maintain a minimum closing bid price of $1.00 per share. The company received formal notification from Nasdaq confirming this compliance status.
Outlook, Risks, and Management Commentary
- Management Action: The company issued a press release on June 4, 2025, regarding the notification, which is filed as Exhibit 99.1.
- Risk Mitigation: The filing indicates the resolution of a potential delisting risk associated with the minimum bid price requirement.
- Unusual Items: None reported beyond the regulatory compliance update.
Investor Verification Checklist
- Verify the current closing bid price of HSDT to ensure continued compliance with the $1.00 threshold.
- Review the press release filed as Exhibit 99.1 for additional context on the compliance period.
- Confirm the company's status as an emerging growth company (indicated as checked in the filing) and its implications for future reporting.